Tuesday, January 10, 2023 episode artwork

EPISODE · Jan 10, 2023 · 7 MIN

Tuesday, January 10, 2023

from The Gist Healthcare Podcast

Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the healthcare industry operates. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the healthcare industry operates. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Tuesday, January 10, 2023

0:00 7:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 7 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on January 10, 2023.

What is this episode about?

Gist Healthcare joins healthcare management consultancy group Kaufman Hall. Biogen’s latest Alzheimer’s drug lecanemab was granted accelerated approval by the FDA. And, the FTC has proposed a ban on non-compete agreements, which could impact how the...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!